Viemed Healthcare (VMD) Cash & Equivalents (2018 - 2026)

Viemed Healthcare has reported Cash & Equivalents for 9 years, with the latest figure at $9.8 million in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 3.92% year-over-year to $9.8 million; the trailing twelve-month figure through Mar 2026 stood at $9.8 million (down 3.92% YoY), and the FY2025 full-year result was $13.5 million, down 23.03% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $9.8 million, down from $13.5 million in the prior quarter.
• The five-year high for Cash & Equivalents was $29.2 million in Q1 2022, with the low at $7.3 million in Q1 2024.
• Historically, Cash & Equivalents has averaged $15.0 million across 5 years, with a median of $12.8 million in 2023.
• Annual changes were most pronounced in 2024 — Cash & Equivalents slumped 68.96% — and 2025, when it surged 127.27%.
• Viemed Healthcare's Cash & Equivalents stood at $16.9 million in 2022, then fell by 24.09% to $12.8 million in 2023, then surged by 36.62% to $17.5 million in 2024, then retreated by 23.03% to $13.5 million in 2025, then fell by 27.69% to $9.8 million in 2026.
• The last three Cash & Equivalents figures came in at $9.8 million (Q1 2026), $13.5 million (Q4 2025), and $11.1 million (Q3 2025), per Business Quant data.